http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2012091589-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_7301487c3ca373a248d3875888e74a46
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_c43c463995072c08ad9791ae5686959a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_9faf5b7c33928c2e1c408e19221872d7
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_9446636975c0bd7b24f17d5a17e5585b
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K36-35
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-22
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-22
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K36-35
filingDate 2011-12-29-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2bd0a911d50b196651f2ba7acc8d099d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_89d9ae7689059e3f2ff8cbc5db44677c
publicationDate 2012-07-05-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber WO-2012091589-A1
titleOfInvention The use of viburnum opulus or its tissues or products thereof for the prevention or treatment of herpes virus infections
abstract We claim the use of preparations of Viburnum opulus fruit in the prevention and therapy of HSV infections. The preparations exhibit a multifactor activity, both by depressing virus replication in infected cells, as well as via a protective effect on cells, thereby lowering their sensitivity to HSV infection. For this reason they may be used both in the prophylaxis of virus infections as well as in the therapeutic treatment of extant HSV infections. The properties of the preparations enable them to be used as the active ingredients of ointments or creams for external use as well as an active ingredient of pills for oral administration.
priorityDate 2010-12-30-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-9522254-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7306815-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2005112215-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-0230404-A2
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128610196
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226435105
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128732261
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID135398635
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226410546
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID135398513
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID12620
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226395421
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128771931

Total number of triples: 30.